XML 70 R61.htm IDEA: XBRL DOCUMENT v3.25.0.1
Acquisitions - Fair Value of Net Assets Acquired (Detail) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 02, 2024
Dec. 31, 2023
Oct. 02, 2023
Apr. 17, 2023
Dec. 31, 2022
Business Acquisition [Line Items]            
Other assets, long-term $ 868   $ 1,277      
Goodwill 1,030,995   987,120     $ 855,513
Tantti Laboratory Inc.            
Business Acquisition [Line Items]            
Cash and cash equivalents 85          
Accounts receivable 1          
Inventory 41          
Prepaid expenses and other current assets 321          
Property and equipment 731          
Operating lease right of use asset 637          
Other assets, long-term 81          
Developed technology / Customer relationships   $ 28,900        
Goodwill 47,105          
Accounts payable (18)          
Accrued liabilities (510)          
Operating lease liability (214)          
Noncurrent deferred tax liability (1,911)          
Noncurrent operating lease liability (413)          
Fair value of net assets acquired 74,846          
Tantti Laboratory Inc. | Developed technology            
Business Acquisition [Line Items]            
Developed technology / Customer relationships 28,910          
Metenova Holding AB            
Business Acquisition [Line Items]            
Cash and cash equivalents 5,768          
Accounts receivable 3,730          
Inventory 4,477          
Prepaid expenses and other current assets 470          
Property and equipment 433          
Operating lease right of use asset 615          
Developed technology / Customer relationships       $ 58,800    
Goodwill 115,722   115,700      
Accounts payable (1,432)          
Accrued liabilities (2,934)          
Operating lease liability (275)          
Noncurrent deferred tax liability (12,481)          
Noncurrent operating lease liability (255)          
Fair value of net assets acquired 172,600          
Metenova Holding AB | Customer relationships            
Business Acquisition [Line Items]            
Developed technology / Customer relationships 12,659          
Metenova Holding AB | Developed technology            
Business Acquisition [Line Items]            
Developed technology / Customer relationships 44,377          
Metenova Holding AB | Trademark and tradename            
Business Acquisition [Line Items]            
Developed technology / Customer relationships 939          
Metenova Holding AB | Non-compete agreements            
Business Acquisition [Line Items]            
Developed technology / Customer relationships 787          
FlexBiosys, Inc.            
Business Acquisition [Line Items]            
Cash and cash equivalents 1,090          
Accounts receivable 683          
Inventory 667          
Prepaid expenses and other current assets 35          
Property and equipment 12,034          
Operating lease right of use asset 3,537          
Other noncurrent assets 10          
Developed technology / Customer relationships         $ 12,600  
Goodwill 14,321   $ 14,300      
Accounts payable (136)          
Accrued liabilities (314)          
Operating lease liability (39)          
Noncurrent operating lease liability (3,498)          
Fair value of net assets acquired 41,030          
FlexBiosys, Inc. | Customer relationships            
Business Acquisition [Line Items]            
Developed technology / Customer relationships 2,530          
FlexBiosys, Inc. | Developed technology            
Business Acquisition [Line Items]            
Developed technology / Customer relationships 9,860          
FlexBiosys, Inc. | Trademark and tradename            
Business Acquisition [Line Items]            
Developed technology / Customer relationships 30          
FlexBiosys, Inc. | Non-compete agreements            
Business Acquisition [Line Items]            
Developed technology / Customer relationships $ 220